Compare the Therapeutic Effect Treated With Tamsulosin and Progesterone After ESWL( Extra Corporeal Shock Wave Lithotripsy) in Urinary Calculus

NCT01010048 | Unknown Phase 4 DMC

• 1 other identifier: CQMU
• Study Type: interventional
• Target: 120
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to compare the stone clearance rate treated with different drugs after ESWL in urinary calculus,These drugs are often used in urinary calculus,such as progesterone,tamsulosin,propantheline Bromide and nifedipine.In these study the investigators want to investigate different effect of these drugs use to treat urinary calculus after ESWL.

Conditions

Urinary Calculus

Keywords

ESWL; urinary calculus; drugs treat

Outcome Measures

Primary Outcomes (1)

• different effect of these drugs use to treat urinary calculus after ESWL

  2weeks

Study Arms (1)

progesterone,tamsulosin,propantheline Bromide and nifedipine

EXPERIMENTAL

different effect of these drugs use to treat urinary calculus after ESWL

Drug: progesterone,tamsulosin,propantheline Bromide and nifedipine

Interventions

progesterone,tamsulosin,propantheline Bromide and nifedipine DRUG

clearance rate of stone

progesterone,tamsulosin,propantheline Bromide and nifedipine

Eligibility Criteria

• Age: 18 Years - 68 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• From 18 years old to 68 years old,
• urinary calculus could be treated by ESWL,
• the calculus size is from 4-25mm

You may not qualify if:

• Less than 18 years old or more than 68 years old,
• the calculus size is from Less than4 or larger than 25mm

Sponsors & Collaborators

• Chongqing Medical University: lead

Study Sites (1)

The First Affiliated Hospital, ChongQing medical University

Chongqing, Chongqing Municipality, 400016, China

RECRUITING

MeSH Terms

Conditions

Urinary Calculi

Interventions

Progesterone; Nifedipine

Condition Hierarchy (Ancestors)

Urolithiasis; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Calculi; Pathological Conditions, Anatomical; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Pregnenediones; Pregnenes; Pregnanes; Steroids; Fused-Ring Compounds; Polycyclic Compounds; Corpus Luteum Hormones; Gonadal Hormones; Hormones; Hormones, Hormone Substitutes, and Hormone Antagonists; Progesterone Congeners; Gonadal Steroid Hormones; Dihydropyridines; Pyridines; Heterocyclic Compounds, 1-Ring; Heterocyclic Compounds

Study Officials

• xiaohou wu, doctor

  First Affiliated Hospital of Chongqing Medical University

  STUDY CHAIR

Central Study Contacts

Yunfeng He, Doctor

CONTACT

86-23-89011121

Xiaohou Wu, Doctor

CONTACT

86-23-89011122

Study Design

• Study Type: interventional
• Phase: phase 4
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: November 6, 2009
• First Posted: November 9, 2009
• Study Start: October 1, 2009
• Primary Completion: October 1, 2009
• Study Completion: December 1, 2010
• Last Updated: November 13, 2009

Record last verified: 2009-11

Locations

CN (1)